Remifentanil With or Without Lidocaine for Extubation After Thyroid Surgery
Official title: Comparison of the Effects of Remifentanil and Remifentanil-Lidocaine Combination on Tracheal Extubation Quality in Patients Undergoing Thyroidectomy
Run by Pamukkale University · NCT07857356 · Data updated 2026-11-12
This study tests whether adding intravenous lidocaine to remifentanil during awakening reduces coughing after thyroidectomy extubation in adults.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Pamukkale University Academic / other |
| Locations | 1 site (Denizli) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07857356 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 years undergoing elective thyroidectomy under general anesthesia, ASA I–II, with BMI <35 kg/m².
✕Probably not a fit
Patients with chronic respiratory disease, airway abnormalities, or lidocaine allergy may not benefit and could be at higher risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized, double-blind trial, 60 adults undergoing elective thyroidectomy will receive remifentanil during emergence from anesthesia, with half also receiving intravenous lidocaine before extubation. The study compares coughing during tracheal extubation and also looks at cough severity, vital signs, airway events, sore throat, hoarseness, nausea and vomiting, sedation, and recovery times. Outcomes will indicate if lidocaine plus remifentanil provides a smoother, safer extubation than remifentanil alone. The trial is parallel-group and conducted at Pamukkale University Hospitals. Patients meet standard anesthesia criteria and will be assessed for eligibility and safety throughout.
Why it matters
Potential benefit: If lidocaine adds benefit, patients may experience less coughing and smoother recovery after thyroidectomy extubation.
How similar studies have gone: Prior strategies using airway reflex-modulating drugs have shown reductions in coughing during extubation in similar surgical populations, though this exact lidocaine-plus-remifentanil approach is being studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 65 years American Society of Anesthesiologists (ASA) physical status I or II Scheduled for elective thyroidectomy under general anesthesia Body mass index (BMI) \<35 kg/m² Able to provide written informed consent Exclusion Criteria: * History of chronic respiratory disease, including asthma or chronic obstructive pulmonary disease (COPD) Active upper or lower respiratory tract infection Known airway abnormality or anticipated difficult airway Known allergy or hypersensitivity to lidocaine Planned postoperative intubation or extubation in the intensive care unit Refusal to participate or withdrawal of consent
Where it's running
-
Pamukkale University Hospitals
Denizli, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: saadet nur YALCIN SATICI — Pamukkale University
- Study coordinator: saadet nur YALCIN SATICI
- Email: yalcinsaadetnur@gmail.com
- Phone: +905066474672
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oliceridine vs Sufentanil for cough during anesthesia induction
This trial tests whether oliceridine is better than sufentanil at reducing cough during anesthesia induction in adults undergoing elective surgery.
-
Combined acupressure to reduce post-thoracotomy pain and improve lung volume
This trial will try combined acupressure on patients after thoracotomy to see if it reduces postoperative pain and helps restore lung volume.
-
Two CE‑marked throat sprays for adults with a recent dry or productive cough
This study will try two CE‑marked throat sprays to see if adults with a recent viral cough tolerate them well and get symptom relief.
-
Rengalin liquid for dry cough in children aged 6 months to 3 years
This will test whether Rengalin liquid reduces dry cough in children 6 months to 3 years old with acute viral upper respiratory infections.
-
Mechanism-guided treatment versus proton-pump inhibitor therapy for chronic throat symptoms
This trial will test whether a mechanism-guided approach combining personalized acid-suppression and voice therapy helps adults (18–89) with chronic throat symptoms more than usual proton pump inhibitor (PPI) treatment.
-
Cough control with dexmedetomidine, magnesium sulfate, or lidocaine after general anesthesia
This study will see if dexmedetomidine, magnesium sulfate, or lidocaine reduces how often and how hard adults cough while waking from general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.